SANUWAVE Health, Inc., a shock wave technology company, focuses on the development and commercialization of noninvasive, high-energy, and acoustic shock waves for regenerative medicine and other applications worldwide. Its shockwaves are used to produce a biological response resulting in the body healing itself through the repair and regeneration of tissue, and musculoskeletal and vascular structures. The company's lead product candidate is the dermaPACE device, which has completed its initial Phase III, IDE clinical trial for treating diabetic foot ulcers. Its portfolio of healthcare products and product candidates activate biologic signaling and angiogenic responses, including new vascularization and microcirculatory improvement, which helps to restore the body's normal healing processes and regeneration. The company also focuses on applying its Pulsed Acoustic Cellular Expression technology in wound healing, orthopedic, plastic/cosmetic, and cardiac conditions. It markets and sells its devices and accessories. SANUWAVE Health, Inc. was founded in 2005 and is headquartered in Suwanee, Georgia.
Industry, Sector and Symbol
Industry N/A
Sub-IndustryN/A
SectorN/A
CIKN/A
WebN/A
PhoneN/A
Debt
Price-To-Earnings
Sales & Book Value
Annual SalesN/A
Profitability
Miscellaneous
Employees14
Next Earnings Date4/3/2020 (Estimated)
OptionableNot Optionable
SANUWAVE Health (OTCMKTS:SNWV) Frequently Asked Questions
What is SANUWAVE Health's stock symbol?
SANUWAVE Health trades on the OTCMKTS under the ticker symbol "SNWV."
How were SANUWAVE Health's earnings last quarter?
SANUWAVE Health, Inc. (OTCMKTS:SNWV) released its quarterly earnings results on Friday, November, 15th. The company reported ($0.01) earnings per share for the quarter, beating the Zacks' consensus estimate of ($0.02) by $0.01. The business had revenue of $0.20 million for the quarter, compared to the consensus estimate of $0.40 million. View SANUWAVE Health's Earnings History.
When is SANUWAVE Health's next earnings date?
Has SANUWAVE Health been receiving favorable news coverage?
Media stories about SNWV stock have been trending negative on Sunday, according to InfoTrie Sentiment. The research group identifies negative and positive press coverage by reviewing more than six thousand news and blog sources. The firm ranks coverage of companies on a scale of negative five to five, with scores nearest to five being the most favorable. SANUWAVE Health earned a media sentiment score of -2.3 on InfoTrie's scale. They also gave news articles about the company a news buzz of 0.0 out of 10, indicating that recent press coverage is extremely unlikely to have an effect on the stock's share price in the next several days. View News Stories for SANUWAVE Health.
What other stocks do shareholders of SANUWAVE Health own?
Who are SANUWAVE Health's key executives?
SANUWAVE Health's management team includes the folowing people:
- Mr. Kevin A. Richardson II, Chairman & CEO (Age 51)
- Mr. Shri P. Parikh, Pres (Age 47)
- Ms. Lisa E. Sundstrom, Chief Financial Officer (Age 50)
- Mr. Peter Stegagno, Chief Operating Officer (Age 59)
- Dr. Iulian Cioanta, Chief Science & Technology Officer (Age 56)
How do I buy shares of SANUWAVE Health?
Shares of SNWV can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.
What is SANUWAVE Health's stock price today?
One share of SNWV stock can currently be purchased for approximately $0.26.
MarketBeat Community Rating for SANUWAVE Health (OTCMKTS SNWV)
| Community Ranking: | | 2.8 out of 5 ( ) |
| Outperform Votes: | | 96 (Thanks for Voting!) |
| Underperform Votes: | | 78 (Thanks for Voting!) |
| Total Votes: | | 174 |
